Perrigo Company plc announced that Jim Dillard, currently Executive Vice President ("EVP") and Chief Scientific Officer, has been named EVP and President, CSCA, effective immediately. In his new role, Mr. Dillard will continue to report to Murray Kessler. Jim Dillard was named EVP and Chief Scientific Officer for Perrigo in January 2019. Mr. Dillard joined Perrigo from Altria Group Inc., where he served as Senior Vice President, Research, Development and Sciences and Chief Innovation Officer. During his tenure with Altria Group, Mr. Dillard led the creation of the Regulatory Affairs function in 2009 and also served as Chief Innovation Officer for Altria Client Services and Senior Vice President of Research, Development & Regulatory Affairs, for Altria Group. Mr. Dillard worked for UST Inc. from 2001 through 2008 where he was President of U.S. Smokeless Tobacco Manufacturing Company (USSTMC) and was responsible for all manufacturing, supply chain, quality and engineering, in addition to the company's Science and Technology organization. Rickard Seeds and GenApps, subsidiaries of UST Inc., also reported to Mr. Dillard. Prior to joining UST Inc., Mr. Dillard worked for the U.S. Food and Drug Administration (FDA) between 1987 and 2001. There he served as Director of the Division of Cardiovascular and Respiratory Devices, as well as in various leadership roles in the Center for Devices and Radiological Health and the Office of Device Evaluation.